Skip to main content

Peer Review reports

From: Lenvatinib targets STAT-1 to enhance the M1 polarization of TAMs during hepatocellular carcinoma progression

Original Submission
14 Nov 2023 Submitted Original manuscript
26 Dec 2023 Reviewed Reviewer Report
20 Jan 2024 Reviewed Reviewer Report - Prasanna K. Santhekadur
20 May 2024 Reviewed Reviewer Report
8 Jul 2024 Author responded Author comments - Jinming Yu
Resubmission - Version 2
8 Jul 2024 Submitted Manuscript version 2
9 Jul 2024 Author responded Author comments - Jinming Yu
Resubmission - Version 3
9 Jul 2024 Submitted Manuscript version 3
17 Jul 2024 Reviewed Reviewer Report
22 Jul 2024 Reviewed Reviewer Report
23 Jul 2024 Author responded Author comments - Jinming Yu
Resubmission - Version 4
23 Jul 2024 Submitted Manuscript version 4
Publishing
23 Jul 2024 Editorially accepted
30 Jul 2024 Article published 10.1186/s12885-024-12680-1

You can find further information about peer review here.

Back to article page